معرفی
Brinton Seashore-Ludlow is an Associate Professor at the Department of Oncology-Pathology, Karolinska Institute (KI), where he serves as team leader in Olli Kallioniemi's research group and group leader of the biology team at Chemical Biology Consortium Sweden (CBCS), SciLifeLab's national infrastructure.
- PhD in Biochemistry, KTH Royal Institute of Technology (2012)
- MSc in Chemical Biology, California Institute of Technology (2007)
- BA in Biochemistry, Macalester College (2001)
His research bridges precision medicine and cancer biology through:
- Developing ex vivo patient-derived models for drug response prediction
- Molecular determinants of therapeutic efficacy
- Integration of high-content imaging with translational studies
- Focus on ovarian, breast, and pediatric cancers
- AI-driven analysis of drug sensitivity data
Recent articles demonstrate:
- 3D tumor spheroid platforms for drug testing
- Epigenetic regulators in neuroblastoma
- Microfluidics for high-throughput assays
- Cancer-stroma interactions in treatment resistance
- Clinical validation of precision diagnostics
He co-organizes the Overview Course in Cancer Drug Discovery at KI and leads projects funded by the Swedish Childhood Cancer Foundation.
۰مقاله منتشرشده
